Showing 12,541 - 12,560 results of 50,030 for search '(( a ((((linear decrease) OR (mean decrease))) OR (larger decrease)) ) OR ( a latest decrease ))', query time: 0.89s Refine Results
  1. 12541

    S1 Data set - by Kalayou K. Berhe (16884067)

    Published 2023
    “…Patients with government employment (AOR = 0.48; 95% CI 0.26, 0.90), antiplatelet drug use (AOR = 0.29; 95% CI 0.16, 0.52), and medication for treating dyslipidemia (AOR = 0.54; 95% CI 0.35, 0.84), all had a decreased chance of developing a chronic diabetes problem.…”
  2. 12542

    <i>as-</i>APF increases p53 expression by modulating USP2a and MDM2 in TRT-HU1, immortalized human normal bladder epithelial cells. by Jayoung Kim (153487)

    Published 2013
    “…(<b>B</b>) Endogenous USP2a level is rapidly decreased in response to <i>as</i>-APF treatment in TRT-HU1 cells. …”
  3. 12543
  4. 12544
  5. 12545

    Acceptance of the HPV vaccine. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  6. 12546

    Cues to the action question. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  7. 12547

    Characteristics of the respondents (n = 2,151). by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  8. 12548

    Determinants of HPV vaccine acceptance. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  9. 12549
  10. 12550
  11. 12551
  12. 12552

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  13. 12553

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  14. 12554
  15. 12555
  16. 12556
  17. 12557
  18. 12558
  19. 12559
  20. 12560